monocrotaline and Hepatic Veno Occlusive Disease

monocrotaline has been researched along with Hepatic Veno Occlusive Disease in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (4.65)	18.7374
1990's	3 (6.98)	18.2507
2000's	6 (13.95)	29.6817
2010's	22 (51.16)	24.3611
2020's	10 (23.26)	2.80

Authors

Authors	Studies
An, L; Chu, X; L, X; Liu, X; Liu, Y; Wang, Y; Zhang, Y	1
Makino, I; Miyashita, T; Munesue, S; Nakanuma, S; Ohbatake, Y; Ohta, T; Okazaki, M; Tajima, H; Takamura, H; Yamamoto, Y; Yamazaki, H	1
Du, L; Liu, C; Liu, F; Song, Y; Wei, N; Xiang, H; Xiao, Z	1
Du, X; Liang, S; Liu, Z; Wei, X; Zhang, J	1
Mei, Q; Ren, X; Xu, J; Xu, K	1
Chen, M; Guo, Q; Huang, Z; Ji, L; Ma, Y; Wang, K; Wu, Z; Yan, S; Zhang, J; Zhao, Q	1
Chen, M; Huang, Z; Ji, L; Lu, B; Wang, Z; Wei, M; Wu, X	1
Chen, M; Huang, Z; Ji, L; Zhang, J; Zhao, Q	1
Guo, H; Guo, T; Kan, X; Liu, C; Liu, F; Meng, L; Rong, X; Song, Y; Xu, D; Yang, X	1
An, LC; Chu, XX; Li, XJ; Liu, XQ; Liu, YH; Wang, YM; Zhang, YF	1
Amano, H; Eshima, K; Goto, T; Ito, Y; Koizumi, W; Majima, M; Otaka, F	1
Hatano, E; Iwaisako, K; Kasai, Y; Nishino, H; Okuno, M; Satoh, M; Seo, S; Taura, K; Toda, R; Yoshino, K	1
Fushida, S; Harada, S; Hayashi, H; Hirata, M; Iseki, S; Makino, I; Miyashita, T; Miyata, T; Nakanuma, S; Nakata, H; Ninomiya, I; Ohta, T; Oyama, K; Tajima, H; Takamura, H; Wakayama, T	1
Fushida, S; Harada, SI; Hayashi, H; Hirata, M; Iseki, S; Makino, I; Miyashita, T; Miyata, T; Nakanuma, SI; Ninomiya, I; Ohta, T; Oyama, K; Tajima, H; Takamura, H; Wakayama, T	1
Huang, Z; Ji, L; Jing, X; Sheng, Y; Zhang, J	1
Chen, M; Hao, Z; Hu, F; Huang, Z; Ji, L; Sheng, Y	1
Oda, S; Takeuchi, M; Tsuneyama, K; Yokoi, T	1
Hayashi, M; Jin, D; Komeda, K; Li, ZL; Masubuchi, S; Okamura, H; Otsuki, Y; Takai, S; Tashiro, K; Uchiyama, K	1
Colet, JM; Conotte, R	1
Hatano, E; Kasai, Y; Miyagawa-Hayashino, A; Nakamura, K; Nishio, T; Okuno, M; Seo, S; Taura, K; Uemoto, S	1
Furihata, M; Honda, G; Ikezoe, T; Nakamura, K; Nishioka, C; Pan, B; Sakai, Y; Xu, K; Yang, J; Yokoyama, A; Yurimoto, H	1
Ji, L; Lu, B; Sheng, Y; Shi, L; Zhang, J; Zheng, Z	1
Jafari, A; Kalff, JC; Manekeller, S; Wehner, S	1
Chen, M; Ji, L; Lu, B; Sheng, Y; Shi, L; Zhang, J; Zheng, Z	1
Cai, JT; Chen, JM; Chen, MY; Du, Q; Shao, LM; Wang, LJ	1
Frossard, JL; Mentha, G; Pastor, CM; Rubbia-Brandt, L; Schiffer, E	1
Ito, Y	1
Asechi, H; Hatano, E; Ikai, I; Nagata, H; Narita, M; Takada, Y; Tamaki, N; Uemoto, S; Yamanaka, K; Yanagida, A	1
Chen, Z; Huo, JR; Yang, L; Zhu, HY	1
Chandrasekaran, VR; Chen, SY; Hsu, DZ; Liu, MY; Periasamy, S; Yang, SS	1
Bast, A; Davies, N; Dejong, CH; Dhar, DK; Ezzat, T; Malagó, M; Olde Damink, SW; van den Broek, MA	1
Chien, SP; Liu, MY; Periasamy, S	1
Hatano, E; Iwaisako, K; Koyama, Y; Miyagawa-Hayashino, A; Nagata, H; Nakamura, K; Narita, M; Taura, K; Uemoto, S	1
Chang, CC; Chen, SY; Liu, MY; Periasamy, S; Yang, SS	1
Friedman, SL	1
An, LC; Fang, T; Hua, J; Liu, MM; Xu, KL; Zeng, LY	1
Deleve, LD; Kanel, G; Strasberg, S; Tokes, ZA; Tsai, J; Wang, X	1
HILL, KR	1
DeLeve, LD; Kaplowitz, N; Kuhlenkamp, JF; Wang, X	1
DeLeve, LD; Epstein, RB; Hu, L; Kanel, GC; McCuskey, MK; McCuskey, RS; Wang, X	1
Gordon, LI	1
Anderson, SL; Epstein, RB; Min, KW; Syzek, L	1
Deeg, HJ; Luk, K; Shulman, HM; Shuman, WB; Storb, R	1

Reviews

1 review(s) available for monocrotaline and Hepatic Veno Occlusive Disease

Article	Year
Chymase inhibition attenuates monocrotaline-induced sinusoidal obstruction syndrome in hamsters. Current medicinal chemistry, 2013, Volume: 20, Issue:21 Topics: Animals; Chymases; Cricetinae; Enzyme Inhibitors; Hepatic Veno-Occlusive Disease; Monocrotaline; Sulfonamides; Thiophenes	2013

Other Studies

42 other study(ies) available for monocrotaline and Hepatic Veno Occlusive Disease

Article	Year
The mouse model of hepatic veno-occlusive disease. Pakistan journal of pharmaceutical sciences, 2021, Volume: 34, Issue:6(Special) Topics: Animals; Cytokines; Disease Models, Animal; Hepatic Veno-Occlusive Disease; Inflammation Mediators; Liver; Liver Cirrhosis; Male; Mice, Inbred BALB C; Monocrotaline; Necrosis; Platelet Activation; Time Factors	2021
Thrombopoietin accumulation in hepatocytes induces a decrease in its serum levels in a sinusoidal obstruction syndrome model. Molecular medicine reports, 2022, Volume: 25, Issue:6 Topics: Animals; Biomarkers; Disease Models, Animal; Female; Hepatic Veno-Occlusive Disease; Hepatocytes; Humans; Mice; Mice, Inbred ICR; Monocrotaline; Rats; Thrombopoietin	2022
Enoxaparin attenuates pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome by inhibiting oncostatin M expression. Liver international : official journal of the International Association for the Study of the Liver, 2023, Volume: 43, Issue:3 Topics: Animals; Anticoagulants; Enoxaparin; Heparin, Low-Molecular-Weight; Hepatic Veno-Occlusive Disease; Mice; Monocrotaline; Oncostatin M; Pyrrolizidine Alkaloids; Rats; Retrospective Studies	2023
Defibrotide improved the outcome of monocrotaline induced rat hepatic sinusoidal obstruction syndrome. BMC gastroenterology, 2022, Dec-16, Volume: 22, Issue:1 Topics: Animals; Anticoagulants; Hepatic Veno-Occlusive Disease; Male; Monocrotaline; Pyrrolizidine Alkaloids; Rats; Rats, Sprague-Dawley	2022
Melatonin attenuates monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats via activation of Sirtuin-3. Journal of biochemical and molecular toxicology, 2023, Volume: 37, Issue:9 Topics: Animals; Endothelial Cells; Hepatic Veno-Occlusive Disease; Liver; Male; Matrix Metalloproteinase 9; Melatonin; Monocrotaline; Rats; Rats, Sprague-Dawley; Sirtuin 3	2023
Andrographolide attenuated MCT-induced HSOS via regulating NRF2-initiated mitochondrial biogenesis and antioxidant response. Cell biology and toxicology, 2023, Volume: 39, Issue:6 Topics: Animals; Antioxidants; Diterpenes; DNA, Mitochondrial; Hepatic Veno-Occlusive Disease; Kelch-Like ECH-Associated Protein 1; Mice; Mice, Knockout; Molecular Docking Simulation; Monocrotaline; NF-E2-Related Factor 2; Organelle Biogenesis; Oxidative Stress; Rats	2023
Liver Inflammatory Injury Initiated by DAMPs-TLR4-MyD88/TRIF-NFκB Signaling Pathway Is Involved in Monocrotaline-Induced HSOS. Toxicological sciences : an official journal of the Society of Toxicology, 2019, 12-01, Volume: 172, Issue:2 Topics: Adaptor Proteins, Vesicular Transport; Alarmins; Animals; Biomarkers; Hepatic Veno-Occlusive Disease; Immunity, Innate; Liver; Liver Function Tests; Male; Mice, Inbred C57BL; Mice, Knockout; Monocrotaline; Myeloid Differentiation Factor 88; NF-kappa B; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4	2019
Liquiritigenin and liquiritin alleviated monocrotaline-induced hepatic sinusoidal obstruction syndrome via inhibiting HSP60-induced inflammatory injury. Toxicology, 2019, 12-01, Volume: 428 Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Chaperonin 60; Flavanones; Glucosides; Hepatic Veno-Occlusive Disease; Liver; Male; Mice; Mitochondria; Monocrotaline; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species	2019
Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study. BMC gastroenterology, 2020, Feb-04, Volume: 20, Issue:1 Topics: Aged; Animals; Ascites; Female; Hepatic Veno-Occlusive Disease; Hepatomegaly; Humans; Liver; Male; Middle Aged; Monocrotaline; Pyrrolizidine Alkaloids; Rats; Rats, Sprague-Dawley; Retrospective Studies; Tomography, X-Ray Computed	2020
[Proventive and Therapentic Effects of Endothelial Progenitor Cells on Monocrotaline-Induced Hepatic Vein Occlusion Disease]. Zhongguo shi yan xue ye xue za zhi, 2020, Volume: 28, Issue:1 Topics: Animals; Endothelial Progenitor Cells; Hepatic Veins; Hepatic Veno-Occlusive Disease; Liver; Mice; Mice, Inbred C57BL; Monocrotaline	2020
Platelets prevent the development of monocrotaline-induced liver injury in mice. Toxicology letters, 2020, Dec-15, Volume: 335 Topics: Animals; Blood Platelets; Cell Survival; Chemical and Drug Induced Liver Injury, Chronic; Coculture Techniques; Endothelial Cells; Hepatic Veno-Occlusive Disease; Liver Function Tests; Male; Mice, Inbred C57BL; Monocrotaline; Platelet Count; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thrombocytosis; Thrombopoietin	2020
Sinusoidal Obstruction Syndrome Promotes Liver Metastatic Seeding of Colorectal Cancer Cells in a Rat Model. Anticancer research, 2021, Volume: 41, Issue:4 Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Disease Progression; Gene Expression Regulation, Neoplastic; Hepatic Veno-Occlusive Disease; Intercellular Adhesion Molecule-1; Liver Neoplasms; Male; Matrix Metalloproteinase 9; Monocrotaline; Rats, Inbred F344; Tumor Burden; Vascular Endothelial Growth Factor A	2021
Extravasated platelet aggregation in the livers of rats with drug‑induced hepatic sinusoidal obstruction syndrome. Molecular medicine reports, 2017, Volume: 15, Issue:5 Topics: Alanine Transaminase; Animals; Antigens, CD34; Aspartate Aminotransferases; Bilirubin; Caspase 3; Hepatic Veno-Occlusive Disease; L-Lactate Dehydrogenase; Liver; Male; Microscopy, Electron; Monocrotaline; P-Selectin; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Rats; Rats, Wistar	2017
Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space. Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:4 Topics: Animals; Antigens, CD34; Capillaries; Cilostazol; Disease Models, Animal; Epithelial Cells; Hepatic Veno-Occlusive Disease; Liver; Male; Monocrotaline; Phosphodiesterase 3 Inhibitors; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Rats, Wistar; Tetrazoles; Time Factors	2018
The involvement of Nrf2 antioxidant signalling pathway in the protection of monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats by (+)-catechin hydrate. Free radical research, 2018, Volume: 52, Issue:4 Topics: Animals; Antioxidants; Catechin; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Hepatic Veno-Occlusive Disease; Humans; Male; Monocrotaline; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Signal Transduction; Stereoisomerism; Structure-Activity Relationship	2018
Liquiritigenin and liquiritin alleviated MCT-induced HSOS by activating Nrf2 antioxidative defense system. Toxicology and applied pharmacology, 2018, 09-15, Volume: 355 Topics: Animals; Antioxidants; Flavanones; Glucosides; Hepatic Veno-Occlusive Disease; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Docking Simulation; Molecular Structure; Monocrotaline; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species	2018
Comprehensive analysis of serum microRNAs in hepatic sinusoidal obstruction syndrome (SOS) in rats: implication as early phase biomarkers for SOS. Archives of toxicology, 2018, Volume: 92, Issue:9 Topics: Animals; Biomarkers; Disease Models, Animal; Gene Expression; Hepatic Veno-Occlusive Disease; Hepatocytes; Liver; Male; MicroRNAs; Monocrotaline; Rats, Sprague-Dawley; Reproducibility of Results	2018
A metabonomic evaluation of the monocrotaline-induced sinusoidal obstruction syndrome (SOS) in rats. Toxicology and applied pharmacology, 2014, Apr-15, Volume: 276, Issue:2 Topics: Animals; Energy Metabolism; Glutathione; Hepatic Veno-Occlusive Disease; Liver; Magnetic Resonance Spectroscopy; Male; Metabolomics; Monocrotaline; Necrosis; Nitric Oxide; Rats; Rats, Wistar	2014
Regorafenib suppresses sinusoidal obstruction syndrome in rats. The Journal of surgical research, 2015, Volume: 193, Issue:2 Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Extracellular Signal-Regulated MAP Kinases; Hepatectomy; Hepatic Veno-Occlusive Disease; Liver; Male; Matrix Metalloproteinase 9; Monocrotaline; Necrosis; Phenylurea Compounds; Phosphorylation; Pyridines; Rats, Sprague-Dawley	2015
The fifth epidermal growth factor-like region of thrombomodulin exerts cytoprotective function and prevents SOS in a murine model. Bone marrow transplantation, 2017, Volume: 52, Issue:1 Topics: Animals; Cytoprotection; Epidermal Growth Factor; Female; Hepatic Veno-Occlusive Disease; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred ICR; Monocrotaline; Protein Domains; Thrombomodulin	2017
Chlorogenic acid suppresses monocrotaline-induced sinusoidal obstruction syndrome: The potential contribution of NFκB, Egr1, Nrf2, MAPKs and PI3K signals. Environmental toxicology and pharmacology, 2016, Volume: 46 Topics: Animals; Chlorogenic Acid; Disease Models, Animal; Early Growth Response Protein 1; Hepatic Veno-Occlusive Disease; Male; Mitogen-Activated Protein Kinase Kinases; Monocrotaline; NF-E2-Related Factor 2; NF-kappa B; Phosphatidylinositol 3-Kinases; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptors; Transcriptional Activation	2016
Sinusoidal obstruction syndrome in the animal model: influence on liver surgery. Langenbeck's archives of surgery, 2017, Volume: 402, Issue:1 Topics: Animals; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Disease Models, Animal; Hepatectomy; Hepatic Veno-Occlusive Disease; Hypoxia; Liver Function Tests; Liver Neoplasms; Male; Monocrotaline; Organoplatinum Compounds; Oxaliplatin; Rats; Rats, Sprague-Dawley	2017
Quercetin and baicalein suppress monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats. European journal of pharmacology, 2017, Jan-15, Volume: 795 Topics: Animals; Early Growth Response Protein 1; Flavanones; Hepatic Veno-Occlusive Disease; Male; MAP Kinase Signaling System; Monocrotaline; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quercetin; Rats; Toll-Like Receptors	2017
Reliable experimental model of hepatic veno-occlusive disease caused by monocrotaline. Hepatobiliary & pancreatic diseases international : HBPD INT, 2008, Volume: 7, Issue:4 Topics: Animals; Cell Proliferation; Disease Models, Animal; Hepatic Veno-Occlusive Disease; Immunohistochemistry; Liver; Liver Regeneration; Male; Monocrotaline; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Time Factors	2008
Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome. Journal of surgical oncology, 2009, Jun-01, Volume: 99, Issue:7 Topics: Animals; Antineoplastic Agents; Colorectal Neoplasms; Disease Models, Animal; Hepatectomy; Hepatic Veno-Occlusive Disease; Liver Regeneration; Monocrotaline; Organoplatinum Compounds; Oxaliplatin; Rats; Rats, Sprague-Dawley	2009
A novel therapeutic strategy for liver sinusoidal obstruction syndrome. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:6 Topics: Animals; Antineoplastic Agents; Hepatic Veno-Occlusive Disease; Humans; Monocrotaline; Neutrophils; Panax; Plant Extracts; Zanthoxylum; Zingiberaceae	2009
Dai-kenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:6 Topics: Animals; Chemokine CXCL1; Hepatic Veno-Occlusive Disease; Intercellular Adhesion Molecule-1; Male; Monocrotaline; Neutrophils; Panax; Peroxidase; Plant Extracts; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Statistics, Nonparametric; Up-Regulation; Zanthoxylum; Zingiberaceae	2009
[Comparison of the hepatic veno-occlusive disease models induced by gynura segetum, monocrotaline and cyclophosphamide]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2010, Volume: 18, Issue:12 Topics: Animals; Cyclophosphamide; Female; Hepatic Veno-Occlusive Disease; Mice; Mice, Inbred Strains; Monocrotaline; Panax notoginseng; Random Allocation	2010
Therapeutic sesamol attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats by inhibiting matrix metalloproteinase-9. Cell biochemistry and biophysics, 2011, Volume: 61, Issue:2 Topics: Animals; Benzodioxoles; Collagen; Down-Regulation; Hepatic Veno-Occlusive Disease; Kupffer Cells; Laminin; Liver; Male; Mast Cells; Matrix Metalloproteinase Inhibitors; Monocrotaline; Neutrophils; Peroxidase; Phenols; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1; Up-Regulation	2011
The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats. Journal of surgical oncology, 2012, Jul-01, Volume: 106, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line, Tumor; Colorectal Neoplasms; Endothelial Cells; Enzyme Induction; Gene Expression Regulation, Enzymologic; Hepatic Veno-Occlusive Disease; Hydroxyethylrutoside; Liver; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Monocrotaline; Organoplatinum Compounds; Oxaliplatin; Oxidative Stress; Portal Pressure; Protective Agents; Rats; Rats, Sprague-Dawley	2012
Therapeutic oral sesame oil is ineffectual against monocrotaline-induced sinusoidal obstruction syndrome in rats. JPEN. Journal of parenteral and enteral nutrition, 2013, Volume: 37, Issue:1 Topics: Administration, Oral; Alanine Transaminase; Animals; Antineoplastic Agents; Antioxidants; Aspartate Aminotransferases; Hepatic Veno-Occlusive Disease; Liver; Male; Monocrotaline; Organoplatinum Compounds; Oxaliplatin; Rats; Rats, Sprague-Dawley; Sesame Oil; Sesamum	2013
Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9. Journal of hepatology, 2012, Volume: 57, Issue:5 Topics: Animals; Disease Models, Animal; Down-Regulation; Hepatectomy; Hepatic Veno-Occlusive Disease; Liver; Male; MAP Kinase Kinase 4; Matrix Metalloproteinase 9; Monocrotaline; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Sorafenib	2012
Prophylactic sesame oil attenuates sinusoidal obstruction syndrome by inhibiting matrix metalloproteinase-9 and oxidative stress. JPEN. Journal of parenteral and enteral nutrition, 2013, Volume: 37, Issue:4 Topics: Animals; Antioxidants; Hepatic Veno-Occlusive Disease; Liver; Male; Matrix Metalloproteinase 9; Monocrotaline; Oxidative Stress; Phytotherapy; Rats; Rats, Sprague-Dawley; Sesame Oil; Sesamum; Tissue Inhibitor of Metalloproteinase-1	2013
Focus. Journal of hepatology, 2012, Volume: 57, Issue:5 Topics: Animals; Cell Transformation, Neoplastic; Epithelial-Mesenchymal Transition; Hepatic Veno-Occlusive Disease; Hepatitis C; Hepatocytes; Humans; Male; MAP Kinase Kinase 4; Matrix Metalloproteinase 9; Monocrotaline; Niacinamide; Phenylurea Compounds; Sorafenib; Viral Nonstructural Proteins	2012
[Effects of liver sinusoid endothelial cell injury in mouse hepatic veno-occlusive disease]. Zhongguo shi yan xue ye xue za zhi, 2012, Volume: 20, Issue:6 Topics: Animals; Endothelial Cells; Endothelium; Hepatic Veins; Hepatic Veno-Occlusive Disease; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Monocrotaline; Platelet Adhesiveness	2012
Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. Gastroenterology, 2003, Volume: 125, Issue:3 Topics: Actins; Animals; Hepatic Veno-Occlusive Disease; Male; Matrix Metalloproteinase Inhibitors; Monocrotaline; Protease Inhibitors; Rats; Rats, Sprague-Dawley	2003
Hepatic veno-occlusive disease produced experimentally in rats by the injection of monocrotaline. Lancet (London, England), 1958, Mar-22, Volume: 1, Issue:7021 Topics: Alkaloids; Animals; Disease; Hepatic Veins; Hepatic Veno-Occlusive Disease; Injections; Liver Diseases; Monocrotaline; Rats	1958
Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology (Baltimore, Md.), 1996, Volume: 23, Issue:3 Topics: Analysis of Variance; Animals; Azathioprine; Buthionine Sulfoximine; Cells, Cultured; Endothelium; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Hepatic Veno-Occlusive Disease; Immunosuppressive Agents; Inactivation, Metabolic; Liver; Methionine Sulfoximine; Mice; Mice, Inbred C3H; Monocrotaline	1996
Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:6 Topics: Animals; Disease Models, Animal; Endothelium; Hemorrhage; Hepatic Veno-Occlusive Disease; Inflammation; Liver; Liver Cirrhosis, Experimental; Male; Monocrotaline; Necrosis; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Time Factors	1999
Gemtuzumab Ozogamicin (Mylotarg) and hepatic veno-occlusive disease: take two acetaminophen, and... Bone marrow transplantation, 2001, Volume: 28, Issue:9 Topics: Acetaminophen; Alkaloids; Aminoglycosides; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cattle; Cattle Diseases; Contraindications; Endothelium; Free Radicals; Gemtuzumab; Glutathione; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Liver; Monocrotaline; Oxidation-Reduction; Oxidative Stress; Transplantation Conditioning	2001
A canine model for hepatic venoocclusive disease. Transplantation, 1992, Volume: 54, Issue:1 Topics: Animals; Bone Marrow Transplantation; Busulfan; Disease Models, Animal; Dogs; Hepatic Veno-Occlusive Disease; Liver; Monocrotaline	1992
Induction of hepatic veno-occlusive disease in dogs. The American journal of pathology, 1987, Volume: 126, Issue:1 Topics: Animals; Busulfan; Buthionine Sulfoximine; Cyclophosphamide; Disease Models, Animal; Dog Diseases; Dogs; Hepatic Veno-Occlusive Disease; Liver; Melphalan; Methionine Sulfoximine; Methotrexate; Monocrotaline; Pyrrolizidine Alkaloids; Radiation Injuries, Experimental; Radiography	1987